This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Embretson, J E Articles by Temin, H M Search for Related Content PubMed PubMed Citation Articles by Embretson, J E Articles by Temin, H M

Transcription from a spleen necrosis virus 5' long terminal repeat is suppressed in mouse cells.

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison 53706.

ABSTRACT

To determine the block(s) to spleen necrosis virus (SNV) replication in mouse cells, we studied the expression of a dominant selectable marker, neo, or a gene whose product is easily assayed, the chloramphenicol acetyltransferase (cat) gene, in SNV-derived and murine leukemia virus-derived vectors. Using transient (CAT) and stable (Neor phenotype) transfection assays, we showed that the SNV promoter was used in mouse cells only when the 3' SNV long terminal repeat (LTR) was absent. Infection of mouse cells with recombinant SNV viruses was 1% as efficient as infection of permissive dog (D17) cells. The SNV proviruses in mouse cells appeared normal by Southern blot analysis, indicating that their integration probably occurred by normal mechanisms. S1 nuclease analyses of Neor mouse cell clones, each harboring a single recombinant SNV provirus, showed that the selected (internal) promoter was active, but that the 5' SNV LTR promoter was not. However, in the rare (less than 10(-6)) Neor colonies in which expression of the 5' LTR was selected, both promoters were active. Thus, the block to SNV infection of mouse cells is at least at two levels; one is a 100-fold-decreased efficiency at some step(s) up to and including integration, and the other is at transcription.

This article has been cited by other articles:

• Hu, W.-S., Pathak, V. K. (2000). Design of Retroviral Vectors and Helper Cells for Gene Therapy. Pharmacol. Rev. 52: 493-512 [Abstract] [Full Text]  
• Gautier, R., Jiang, A., Rousseau, V., Dornburg, R., Jaffredo, T. (2000). Avian Reticuloendotheliosis Virus Strain A and Spleen Necrosis Virus Do Not Infect Human Cells. J. Virol. 74: 518-522 [Abstract] [Full Text]  
• Certo, J. L., Shook, B. F., Yin, P. D., Snider, J. T., Hu, W.-S. (1998). Nonreciprocal Pseudotyping: Murine Leukemia Virus Proteins Cannot Efficiently Package Spleen Necrosis Virus-Based Vector RNA. J. Virol. 72: 5408-5413 [Abstract] [Full Text]  
• Yang, Z., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., Nabel, G. J. (1998). Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins. Science 279: 1034-1037 [Abstract] [Full Text]  
• Zhang, J, Temin, H. (1993). Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science 259: 234-238 [Abstract]